About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 5696 record(s)
Req # A-2019-001922
Adverse Reaction Report (AER) for Guanfacine. Report number: E2B_02774351.Organization: Health Canada
March 2020
Req # A-2019-001927
Adverse Reaction Report (AER) for Cuvitru. Report number: 000732250.Organization: Health Canada
March 2020
Req # A-2019-001958
Adverse Reaction Report (AER). Report numbers: E2B_02777617, E2B_02779836.Organization: Health Canada
March 2020
Req # A-2019-001959
Adverse Reaction Report (AER). Report numbers: 000731315, E2B_02843753, E2B_02851346, E2B_02852105.Organization: Health Canada
March 2020
Req # A-2019-001971
Adverse Reaction Report (AER). Report number: 000731565.Organization: Health Canada
March 2020
Nothing to report this month
Organization: Canada Foundation for Innovation
Req # A-2020-00008
Please provide a copy of the original loan agreement between Export Development Canada and the loan recipient, which was subsequently mentioned as a write-off of $196, 010, 248 from Export Development Canada's Canada Account, as mentioned in…Organization: Export Development Canada
February 2020
Req # A-2020-00009
Please provide all records, files, and documents, including electronic correspondence and data, sent/rec by officials at the DG, ADM or DM level regarding the write-off of $196, 010, 248 from Export Development Canada's Canada Account, as…Organization: Export Development Canada
February 2020
Req # A-2013-000029
Correspondence between the sponsor and Health Canada relating to the approval of APO-MOMETASONE (AQUEOUS NASAL SPRAY).Organization: Health Canada
February 2020
Req # A-2016-000178
Reviewer’s notes for Estragyn Vaginal Cream (Estrone Vaginal Cream) marketed by Searchlight Pharma Inc.Organization: Health Canada
February 2020